The Compassionate Allowances program helps the Social Security Administration (SSA) identify people living with rare and serious medical conditions that render patients disabled. According to SSA Acting Commissioner Kilolo Kijakazi, the Compassionate Allowances program is the SSA’s way of “reducing barriers and ensuring people who are eligible for benefits receive them.”
12 New Compassionate Allowance Conditions
The SSA added 12 new conditions to the program in August 2023. The following conditions now qualify for the Compassionate Allowances program:
- Ip36 Deletion Syndrome
- Anaplastic Ependymoma
- Calciphylaxis
- Cholangiocarcinoma
- FOXGI Syndrome
- Leber Congenital Amaurosis
- Metastatic Endometrial Adenocarcinoma
- Paraneoplastic Cerebellar Degeneration
- Pineoblastoma – Childhood
- Primary Omental Cancer
- Sarcomatoid Carcinoma of the Lung – Stages II-IV
- Trisomy 9
Adding these conditions to the Compassionate Allowances list helps patients get the benefits they need more quickly. These conditions are rare and usually severe. The unpredictable nature of some of these illnesses makes fast approval of disability benefits more helpful to beneficiaries. Medical confirmation of one of these diagnoses is enough to qualify for Social Security disability benefits. Currently, 278 conditions qualify for Compassionate Allowances.
Contact Us Today
Clancy & Associates, Ltd., is the only full-service special needs planning law firm in Illinois. Our attorneys are dedicated to supporting individuals with special needs and their families. We, too, are parents and siblings of loved ones who have a disability and know how daunting and exhausting it is to go from firm-to-firm and provider-to-provider to find solutions and help.
Each child and family’s needs are very different — and we provide tailored, common sense ideas and strategies that reflect your goals, resources, and hopes for your family’s future security.
Contact us today to schedule a consultation to learn more about our services and talk about your planning needs.
